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C O R R E S P O N D E N C E  1 5 1
and t r o p e  (a turning), and has been used previously to 
distinguish the ichthyosiform  naevus in  the CH ILD  syndrome, 
w hich has a pronounced affin ity for the body folds, from all 
other naevi or naevoid conditions w hich  are not ptycho- 
tropic . 8
A  3 4 -year-old m an presented w ith  a p ruritic dermatosis 
confined to the natal cleft. The disease had been present for 9  
years, and had gradually become m ore extensive. Previous 
treatm ent had consisted of topical steroids, w h ich  relieved the 
pruritus but did not otherw ise influence the lesions. There was 
no fam ily history of sim ilar skin lesions, or of porokeratosis. On 
exam ination, there were m ultiple erythem atous, keratotic 
papules, w hich were discrete at the m argins of the affected 
area, but coalesced towards the centre to form  a plaque (Fig. 
1 ). The rest of the skin was norm al.
Histology of a skin biopsy showed orthohyperkeratosis, 
acanthosis, and papillom atosis of the epiderm is, and typical 
cornoid lam ellae. Beneath the cornoid lam ellae, the granular 
cell layer was absent, and there w ere num erous dyskeratotic 
cells. There was a non-specific m ononuclear cell in filtrate in  
the upper dermis (Fig. 2 ). Focally these lesions were found to 
extend into the h a ir follicles.
He was treated w ith  topical all-£rans-retinoic acid 0 *0 5 % ,
i
w hich was applied th in ly and evenly once daily. Despite some 
slight im provem ent after 1  m onth, the treatm ent was 
eventually discontinued because of unacceptable irrita tion  of 
the skin.
The characteristic histological feature of a ll porokeratotic 
variants is the cornoid lam ella. C lin ically, most types of 
porokeratosis consist of lesions characterized by central 
atrophy and a hyperkeratotic m argin. Hyperkeratotic lesions 
w ith  a centrally keratotic or even verrucous surface m ay be 
found in  linear prokeratosis and porokeratosis of M ibelli. 9  
Porokeratotic lesions usually rem ain asym ptom atic, although 
intense pruritus has been reported to occur in  dissem inated 
superficial porokeratosis. 1 0
The morphology and localization of the lesions in  our 
patient differ from the known clin ica l variants of poroker­
atosis, and we consider these features m ay represent a 
distinctive type of porokeratosis invo lving  the body folds. W e 
propose the designation ‘porokeratosis ptychotropica’ to 
distinguish this porokeratotic variant.
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More than 1000J /cm 2 of UVA for PUVA treatment of 
psoriasis
Sir, The guidelines for m anagem ent of patients w ith  psoriasis 
produced by the W orkshop of the Research U nit o f the Royal 
College of Physicians of London, the Departm ent of Dermato­
logy, U n iversity of Glasgow and the British  Association of 
Derm atologists 1  is a useful document. In  the section on PU VA  
therapy it is stated that the total lifetim e exposure to UVA 
should (if possible) be a m axim um  of 1 0 0 ()J/cm 2. W e were 
aw are that we had m any patients who had exceeded this lim it 
and therefore felt it an im portant subject for audit.
W e have identified 3 7  patients w ith  psoriasis who have 
received over .1 0 0 0 ƒ/cm 2  of U VA  since PU V A  was started in  
Devon in  1 9 8 0  (Table 1 ). The population served Is about 1 * 1  
m illion, and the total num ber of psoriasis patients treated w ith 
PU V A  to date has been approxim ately 3 0 0 .
Our policy is to use a clearing regim en of PU V A , and then 
stop therapy, or sometimes to continue for 2 - 3  months before 
stopping. Most patients therefore have repeated clearing 
courses. The m ajority of hlgh-dose patients are those who 
relapse prom ptly if  PU V A  is stopped, so m any are on virtually 
continuous therapy. AH patients in this group have severe
their psoriasis (Table 2 ).
The m ain reason for continuing PU VA  has been patient 
preference, although we periodically review  all psoriasis 
patients on system ic treatm ent, and discuss alternative 
therapy w ith  them . Squam ous cell carcinom a has occurred 
in  seven patients, to date, in  this group of 3  7  high-dose UVA  
patients (Table 1 ). Most patients who receive PU V A  In our 
area have failed to clear w ith  d lthranol and U VB or, having 
cleared, flared too quickly to make it a practical treatm ent (this 
study presents our findings prior to the introduction of 
calclpotrlol; D ovonex®). A ll system ic agents for the treatm ent 
of psoriasis have side-effects, and it is often considered that
